drugset
Drugs / Vi-TT
last change Dec 2024 re-read 3 minutes ago

Vi-TT

Vaccine

Developed for
typhoid fever
Investigated by
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · Institute of Tropical Medicine, Belgium · International Vaccine Institute · University of Cambridge

Trials 1

today NCT05119426 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05119426 Feb 2022 → Dec 2024 typhoid fever International Vaccine Institute Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vi-TT ClinicalTrials.gov intervention name — accepted as the source's own label NCT05119426 ↗
Modality Vaccine “Single dose of vaccine administered through a mass vaccine campaign” NCT05119426 ↗